MENU

XBIO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Xenetic Biosciences (XBIO) Ownership - Who owns Xenetic Biosciences?

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

945 Concord Street

Phone

+1 781 778-7720

Employees

4

Web

https://www.xeneticbio.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

6.74M

P/E Ratio

N/A

Total Cash

7.35M

Projected Growth

N/A

Total Debt

152.53K

Revenue

3.19M

Risk (Beta)

1.18

Dividend Yield

N/A

Total Cash/Share

3.21

Total Debt/Equity

N/A

Revenue/Share

1.69 USD as % of share price

View a ticker or compare two or three

VS

VS

XBIO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for XBIO

A.I. Advisor

published General Information

General Information

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

945 Concord Street

Phone

+1 781 778-7720

Employees

4

Web

https://www.xeneticbio.com